Ganglioside GM1 Ab:PrThr:Pt:Ser:Ord:IF

Known as: Ganglioside GM1 Antibody:Presence or Threshold:Point in time:Serum:Ordinal:Immune Fluorescence, Ganglioside GM1 , Ac:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:Immunofluorescence, S--monosialoganglioside GM1, Ig; ; IF 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2013
01219902013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
An approach based on liquid chromatography-tandem mass spectrometry was developed for the quantification of monosialogangliosides… (More)
Is this relevant?
2003
2003
The conversion of soluble, nontoxic amyloid beta-protein (A beta) to aggregated, toxic A beta rich in beta-sheet structures is… (More)
Is this relevant?
2003
2003
BACKGROUND Tay-Sachs disease is a form of monosialoganglioside triaose (GM2) gangliosidosis that results from the mutations in… (More)
Is this relevant?
1994
1994
BACKGROUND AND PURPOSE The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1990
1990
We describe the immunomodulatory activity of GM-1/P a processed form of GM-1 (monosialoganglioside) extracted from ox brain… (More)
Is this relevant?
1990
1990
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A… (More)
Is this relevant?